Fresenius Finance Ireland Plc, established in 2007 and headquartered in Dublin, Ireland, serves as a pivotal financing entity for the international healthcare group Fresenius SE & Co. KGaA. The company’s primary purpose is to facilitate funding for Fresenius’ subsidiaries through a range of financial instruments, including bond issuances.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FREGR 0.00% 2025-10-01 EURFresenius Finance Ireland Plc | Ireland | 2025-10-01 | 0.000 | 2.51 |
| FREGR 0.50% 2028-10-01 EURFresenius Finance Ireland Plc | Ireland | 2028-10-01 | 0.500 | 2.63 |
| FREGR 0.88% 2031-10-01 EURFresenius Finance Ireland Plc | Ireland | 2031-10-01 | 0.875 | 3.17 |
| FREGR 2.13% 2027-02-01 EURFresenius Finance Ireland Plc | Ireland | 2027-02-01 | 2.125 | 2.44 |
| FREGR 3.00% 2032-01-30 EURFresenius Finance Ireland Plc | Ireland | 2032-01-30 | 3.000 | 3.24 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inaugural bond issuance in 2008, Fresenius Finance Ireland Plc has actively participated in the debt capital markets, with notable transactions including a €500 million bond offering launched in 2019. This issuance was distinguished by its 10-year maturity and competitive yield, reflecting favorable market conditions. As of now, the company’s bonds typically yield comparably lower than industry averages, showcasing strong demand and investor confidence. Recent market activity includes a focus on sustainability-linked bonds, aligning with Fresenius' commitment to environmental goals, a trend that is gaining traction across the corporate landscape.